The predictive value of uncommon EGFR mutation in patients with non-small-cell lung cancer.

被引：1
|
作者：
Tu, Haiyan
Ke, Ee
Sun, Yue-Li
Zheng, Ming-Ying
Yang, Jin-Ji
Wang, Zhen
Wu, Si-Pei
Su, Jian
Zhang, Xuchao
Bai, Xiao-Yan
Yang, Xue-Ning
Zhong, Wenzhao
Yan, Hong-Hong
Zhou, Qing
Wu, Yi-Long
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.9028
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9028
引用
收藏
页数：6
相关论文
共 50 条
  • [41] The predictive value of serum tumor markers for EGFR mutation in non-small cell lung cancer patients with non-stage IA
    Du, Wenxing
    Qiu, Tong
    Liu, Hanqun
    Liu, Ao
    Wu, Zhe
    Sun, Xiao
    Qin, Yi
    Su, Wenhao
    Huang, Zhangfeng
    Yun, Tianxiang
    Jiao, Wenjie
    [J]. HELIYON, 2024, 10 (09)
  • [42] Prognostic and Predictive Value of Cell Cycle Deregulation in Non-Small-Cell Lung Cancer
    Sterlacci, William
    Fiegl, Michael
    Tzankov, Alexandar
    [J]. PATHOBIOLOGY, 2012, 79 (04) : 175 - 194
  • [43] Predictive value of CD73 expression in EGFR-mutation positive non-small-cell lung cancer patients received immune checkpoint inhibitors.
    Ishii, Hidenobu
    Azuma, Koichi
    Kinoshita, Takashi
    Matsuo, Norikazu
    Naito, Yoshiko
    Tokito, Takaaki
    Yamada, Kazuhiko
    Hoshino, Tomoaki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [44] First-line Afatinib in Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in South Korea
    Kim, Mi-Hyun
    Choi, Chang Min
    Lee, Sung Yong
    Park, Cheol Kyu
    Chang, Yoon Soo
    Lee, Kye Young
    Kim, Seung Joon
    Yang, Sei Hoon
    Ryu, Jeong Seon
    Lee, Jeong Eun
    Lee, Shin Yup
    Park, Chan Kwon
    Lee, Sang Hoon
    Jang, Seung Hun
    Yoon, Seong Hoon
    Jang, Tae Won
    [J]. ANTICANCER RESEARCH, 2022, 42 (03) : 1615 - 1622
  • [45] Uncommon Mutation Types of EGFR and Response to EGFR Tyrosine Kinase Inhibitors in Chinese Non-Small Cell Lung Cancer Patients
    Chen, K.
    Yu, X.
    Wang, H.
    Huang, Z.
    Xu, Y.
    Gong, L.
    Fan, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2131 - S2131
  • [46] Multi-genomic analysis of compound and uncommon EGFR mutations in patients with non-small cell lung cancer.
    Park, Jayoung
    Lee, Yu Min
    Ka, Sojeong
    Kim, Seoree
    Kim, In-Ho
    Sung, Yeoun Eun
    Jung, Chan-Kwon
    Shin, Jung-Young
    Chun, Sang Hoon
    Lee, Young Ho
    Kang, Jin Hyoung
    Kim, Joori
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [47] Local complications of non-small-cell lung cancer.
    Sonett J.R.
    [J]. Current Treatment Options in Oncology, 2002, 3 (1) : 59 - 65
  • [48] Clinical outcome of treatment of metastatic non-small cell lung cancer in patients harboring uncommon EGFR mutation
    J. Chantharasamee
    N. Poungvarin
    P. Danchaivijitr
    S. Techawatanawanna
    [J]. BMC Cancer, 19
  • [49] Clinical outcome of treatment of metastatic non-small cell lung cancer in patients harboring uncommon EGFR mutation
    Chantharasamee, J.
    Poungvarin, N.
    Danchaivijitr, P.
    Techawatanawanna, S.
    [J]. BMC CANCER, 2019, 19 (1)
  • [50] Customized Chemotherapy on the Basis of EGFR Mutation Status for Elderly Patients With Advanced Non-Small-Cell Lung Cancer
    Kunimasa, K.
    Katakami, N.
    Masago, K.
    Yoshioka, H.
    Tomii, K.
    Kaneda, T.
    Hirabayashi, M.
    Morizane, T.
    Fujita, S.
    Mio, T.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S280 - S280
12345